32 results
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
Policy and Foreign Corrupt Practices Act, Bribery Act and Anti-Corruption Policy.
the need to act fairly between members of the company
The Board … to have such an effect: health and safety, anti-bribery, employment law, human medicines regulations and clinical trial legislation recognising
DEFA14A
10dup
23 May 23
Additional proxy soliciting materials
4:08pm
DEFA14A
aeoi7r9lo lbe3qv
9 Jun 22
Additional proxy soliciting materials
9:06am
10-K
muiblpp77jnpdi76
30 Mar 22
Annual report
12:00am
10-Q
p4zkg3
16 Aug 21
Quarterly report
7:07am
424B4
ju2ddzu3 78bcrjkfqz
1 Jun 21
Prospectus supplement with pricing info
4:07pm
S-1/A
ximlq oxxq1uylkq
12 May 21
IPO registration (amended)
5:19pm